Antifungal and Antiparasitic Drug Delivery
undefined
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (168 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03003nam-a2201057z--4500 | ||
|---|---|---|---|
| 001 | 993546355204498 | ||
| 005 | 20240124200749.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202105s2020 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5400000000044368 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68705 | ||
| 035 | |a (EXLCZ)995400000000044368 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Torrado Durán, Juan José |4 edt | |
| 245 | 1 | 0 | |a Antifungal and Antiparasitic Drug Delivery |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (168 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a undefined | ||
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 653 | |a vaccine | ||
| 653 | |a adjuvants | ||
| 653 | |a Sporothrix schenckii | ||
| 653 | |a toluene | ||
| 653 | |a virulence | ||
| 653 | |a enolase | ||
| 653 | |a Montanide PetGel A | ||
| 653 | |a Amphotericin B | ||
| 653 | |a cutaneous leishmaniasis | ||
| 653 | |a hydrogel | ||
| 653 | |a wound dressing | ||
| 653 | |a controlled release | ||
| 653 | |a thermoreversible gel | ||
| 653 | |a poloxamer 407 | ||
| 653 | |a candidiasis | ||
| 653 | |a amphotericin B | ||
| 653 | |a skin and vaginal mucosa | ||
| 653 | |a butenafine | ||
| 653 | |a SNEDDS | ||
| 653 | |a solid SNEDDS | ||
| 653 | |a spray drying | ||
| 653 | |a leishmaniasis | ||
| 653 | |a design of experiments | ||
| 653 | |a orodispersible films | ||
| 653 | |a fast-dissolving films | ||
| 653 | |a micelles | ||
| 653 | |a fungal infections | ||
| 653 | |a aspergillosis | ||
| 653 | |a oral delivery | ||
| 653 | |a chitosan | ||
| 653 | |a shiitake | ||
| 653 | |a Lentinula edodes | ||
| 653 | |a AHCC® | ||
| 653 | |a Molecular Envelope Technology | ||
| 653 | |a praziquantel | ||
| 653 | |a calcium carbonate | ||
| 653 | |a schistosomiasis | ||
| 653 | |a bioavailability | ||
| 653 | |a solubility | ||
| 653 | |a cytotoxicity | ||
| 653 | |a fluconazole | ||
| 653 | |a orthopedic infection | ||
| 653 | |a Poly(d,l-lactide-co-glycolide) beads | ||
| 653 | |a sustained release | ||
| 653 | |a Leishmania infantum | ||
| 653 | |a meglumine antimoniate | ||
| 653 | |a Sepigel 305® | ||
| 653 | |a topical treatment | ||
| 653 | |a polymer micelles | ||
| 653 | |a drug delivery | ||
| 653 | |a liposomes | ||
| 653 | |a transferosomes | ||
| 653 | |a nanoparticles | ||
| 653 | |a emulsions | ||
| 653 | |a azoles | ||
| 653 | |a combined therapy | ||
| 653 | |a quality by design | ||
| 653 | |a malaria | ||
| 653 | |a trypanosomiasis | ||
| 776 | |z 3-03936-306-9 | ||
| 776 | |z 3-03936-307-7 | ||
| 700 | 1 | |a Serrano, Dolores R. |4 edt | |
| 700 | 1 | |a Capilla, Javier |4 edt | |
| 700 | 1 | |a Torrado Durán, Juan José |4 oth | |
| 700 | 1 | |a Serrano, Dolores R. |4 oth | |
| 700 | 1 | |a Capilla, Javier |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2024-01-25 02:21:16 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338219120004498&Force_direct=true |Z 5338219120004498 |b Available |8 5338219120004498 | ||